◆英語タイトル：Neuren Pharmaceuticals Ltd (NEU) - Financial and Strategic SWOT Analysis Review
Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company provides pipeline products such as trofinetide and NNZ-2591. Its trofinetide has a pharmacokinetic profile, which is suitable for intravenous infusion and oral delivery. Neuren Pharma undertakes clincal trials for several drugs. The company’s trofinetide is a clinical stage drug candidate it provides molecule which is derived from IGF-1 and occurs naturally in the brain. Its drugs are also used in neurodevelopmental disorders such as angelman syndrome and idiopathic autism, or neurodegenerative disorders such as Parkinson’s disease and multiple sclerosis. Neuren Pharma is headquartered in Camberwell, Victoria, Australia.
Neuren Pharmaceuticals Ltd Key Recent Developments
Feb 27,2019: Neuren Pharmaceuticals: Preliminary final report for the financial year ended 31 December 2018
Dec 18,2018: Neuren Pharmaceuticals: 2018 year-end business update
Dec 17,2018: Larry Glass to retire as a director and continue as chief science officer
Oct 31,2018: Neuren Pharmaceuticals: Appendix 4C report for the quarter ended 30 September 2018
Sep 22,2018: FDA reaffirms positive benefit-risk of ACADIA”s NUPLAZID
This comprehensive SWOT profile of Neuren Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neuren Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Neuren Pharmaceuticals Ltd – Key Information
Neuren Pharmaceuticals Ltd – Overview
Neuren Pharmaceuticals Ltd – Key Employees
Neuren Pharmaceuticals Ltd – Key Employee Biographies
Neuren Pharmaceuticals Ltd – Key Operational Heads
Neuren Pharmaceuticals Ltd – Major Products and Services
Neuren Pharmaceuticals Ltd – History
Neuren Pharmaceuticals Ltd – Company Statement
Neuren Pharmaceuticals Ltd – Locations And Subsidiaries
Neuren Pharmaceuticals Ltd – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Neuren Pharmaceuticals Ltd – Business Description
Neuren Pharmaceuticals Ltd – Corporate Strategy
Neuren Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Neuren Pharmaceuticals Ltd – Strengths
Neuren Pharmaceuticals Ltd – Weaknesses
Neuren Pharmaceuticals Ltd – Opportunities
Neuren Pharmaceuticals Ltd – Threats
Neuren Pharmaceuticals Ltd – Key Competitors
Section 3 – Company Financial Performance Charts
Neuren Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Neuren Pharmaceuticals Ltd, Key Information
Neuren Pharmaceuticals Ltd, Key Ratios
Neuren Pharmaceuticals Ltd, Share Data
Neuren Pharmaceuticals Ltd, Major Products and Services
Neuren Pharmaceuticals Ltd, History
Neuren Pharmaceuticals Ltd, Key Employees
Neuren Pharmaceuticals Ltd, Key Employee Biographies
Neuren Pharmaceuticals Ltd, Key Operational Heads
Neuren Pharmaceuticals Ltd, Other Locations
Neuren Pharmaceuticals Ltd, Subsidiaries
Neuren Pharmaceuticals Ltd, Key Manufacturing facilities
Neuren Pharmaceuticals Ltd, Key Competitors
Neuren Pharmaceuticals Ltd, SWOT Analysis
Neuren Pharmaceuticals Ltd, Ratios based on current share price
Neuren Pharmaceuticals Ltd, Annual Ratios
Neuren Pharmaceuticals Ltd, Interim Ratios
Capital Market Ratios
List of Figures
Neuren Pharmaceuticals Ltd, Performance Chart
Neuren Pharmaceuticals Ltd, Ratio Charts
| ★海外企業調査レポート[Neuren Pharmaceuticals Ltd (NEU)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら